Tafenoquine Succinate

CAS No. 106635-81-8

Tafenoquine Succinate ( WR 238605 (Succinate) )

Catalog No. M26474 CAS No. 106635-81-8

Tafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 140 Get Quote
10MG 215 Get Quote
25MG 338 Get Quote
50MG 439 Get Quote
100MG 644 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tafenoquine Succinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Tafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.
  • Description
    Tafenoquine Succinate is an 8-aminoquinoline. and is an agent of anti-malarial prophylactic.(In Vivo):When tested at two times its ED100 (6 mg/kg), Tafenoquine anti-malarial activity is partially restored in humanized/CYP 2D6 knock-in mice .
  • Synonyms
    WR 238605 (Succinate)
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    microtubule
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    106635-81-8
  • Formula Weight
    581.6
  • Molecular Formula
    C28H34F3N3O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(=O)CCC(O)=O.COc1cc(C)c2c(Oc3cccc(c3)C(F)(F)F)c(OC)cc(NC(C)CCCN)c2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Choi BH, Chattopadhaya S, Thanh le N, Feng L, Nguyen QT, Lim CB, Harikishore A, Nanga RP, Bharatham N, Zhao Y, Liu X, Yoon HS. Suprafenacine, an indazole-hydrazide agent, targets cancer cells through microtubule destabilization. PLoS One. 2014 Oct 29;9(10):e110955.
molnova catalog
related products
  • DDD107498 succinate

    DDD107498 has a potent and novel spectrum of antimalarial activity against multiple life-cycle stages of the Plasmodium parasite. It targets translation elongation factor 2 (eEF2).

  • Emodepside

    A semisynthetic derivative of PF1022A, and novel cyclo-depsipeptide anthelmintic which is efficacious against a variety of gastrointestinal nematodes.

  • ELQ-300

    ELQ-300 is bioavailable antimalarial agent acts as an inhibitor of the reductive (Qi) site of the cytochrome bc1 complex (cyt bc1).